MIP PHARMA DANMARK ApS: Financial statements 2017
CVR: 32886280
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
MIP PHARMA DANMARK ApS (CVR 32886280) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -34,231 and a net result of DKK -39,376 compared with DKK -42,710 the year before. Equity in the 2017 report amounted to DKK -148,813.
- Gross Profit
- DKK -34,231
- Profit/Loss
- DKK -39,376
- Equity
- DKK -148,813
- Total Assets
- DKK 15,054
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -34 t. | -39 t. | -149 t. | - |
| 2016 | - | -34 t. | -43 t. | -109 t. | - |
| 2015 | - | -42 t. | -47 t. | -67 t. | - |
| 2014 | - | -32 t. | -34 t. | -20 t. | - |
| 2013 | - | -25 t. | -24 t. | 14 t. | - |
Keep an eye on MIP PHARMA DANMARK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of August 10, 2017, Ursula Seidel is registered as director of MIP PHARMA DANMARK ApS.
As of August 10, 2017, Peter Denk has stepped down as director of MIP PHARMA DANMARK ApS.
About MIP PHARMA DANMARK ApS
MIP PHARMA DANMARK ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jochen Steinhage. The company is owned by MIP Pharma GmbH. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -129,052 and a net result of DKK -155,646 compared with DKK -109,135 the year before. Equity in the 2025 report amounted to DKK -716,683.